本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AC Immune SA

2.68
+0.02000.75%
盤後2.680.00000.00%19:30 EDT
成交量:9.35萬
成交額:24.75萬
市值:2.73億
市盈率:-5.09
高:2.70
開:2.65
低:2.59
收:2.66
52周最高:4.00
52周最低:2.10
股本:1.02億
流通股本:3,918.55萬
量比:0.75
換手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):-0.5264
每股收益(LYR):-0.8828
淨資產收益率:-78.53%
總資產收益率:-16.04%
市淨率:6.35
市盈率(LYR):-3.04

資料載入中...

2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/13

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/30

SEC問詢函

Form CORRESP - Correspondence
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/20

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities